5Hirsh J, Dalen JE, Deykin D, et al. Oral anticoagulants, Mechanism of action clinical effectiveness, and optimal therapeutic range. Chest,1992, 102(4 Suppl): 312 - 314.
6Horstkotte D, Schulte H, Bircks W, et al. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude medical prostheses. J Heart Valve Dis, 1993, 2 (3): 291 - 293.
7Katircioglu SF, Yamak B, Ulus AT, et al. Mitral valve replacement with St. Jude medical prosthesis and low dose anticoagulation in patients aged over 50 years. JHeart Valve Dis, 1998, 7(4): 455 -458.
8Kanaaoka Y, Tanemoto K, Murakami T, et al. Thromboemblic and bleeding complications in patients treated with oral anticoagulant therapy after mechanical heart valve prostheses implantation. Kyobu Geka, 2000, 53(9): 754 -757.
9Cortelazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoaguloation clinic. Thromb Haemost, 1993, 69 (4):316 - 320.
